1. Reporting Coefficient of Variation for Logit, Box-Cox and Other Non-log-normal Parameters

   • John P. Prybylski

   Commentary 01 February 2024 Pages: 133 - 135

2. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Moderate-to-Severe Psoriasis

   • Jonathan Greenzaid
   • Steven Feldman

   Review Article 27 January 2024 Pages: 137 - 153

   

3. Use of Pharmacokinetic and Pharmacodynamic Data to Develop the CDK4/6 Inhibitor Ribociclib for Patients with Advanced Breast Cancer

   • Yan Ji
   • Hilmar Schiller
   • Abhijit Chakraborty

   Review Article Open access 20 January 2024 Pages: 155 - 170

   

4. Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung Cancer

   • Joseph Chen
   • Alessandra Bearz
   • Yazdi K. Pithavala

   Original Research Article Open access 11 December 2023 Pages: 171 - 182

   

5. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step

   • Jessica Le Blanc
   • Denis Projean
   • Amélie Marsot

   Original Research Article 21 December 2023 Pages: 183 - 196

   

6. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis

   • Maddalena Centanni
   • Mirjam E. van de Velde
   • Lena E. Friberg

   Original Research Article Open access 23 December 2023 Pages: 197 - 209

   

7. Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass

   • Audrick Gibert
   • Julien Lanoiselée
   • Edouard Ollier

   Original Research Article 02 January 2024 Pages: 211 - 225

   

8. Pharmacokinetics, Pharmacodynamics, and Safety of Single Dose HSK7653 Tablets in Chinese Subjects with Normal or Impaired Renal Function

   • Dan Shi
   • Lin Chen
   • Dongliang Zhang

   Original Research Article 06 January 2024 Pages: 227 - 239

   

9. Pharmacokinetics, Disposition, and Biotransformation of [¹⁴C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion

   • Elijah Weber
   • Raju Subramanian
   • Renu Singh

   Original Research Article 18 January 2024 Pages: 241 - 253

   

10. Population Pharmacokinetic Modeling of Cotadutide: A Dual Agonist Peptide of Glucagon-Like Peptide and Glucagon Receptors Administered to Participants with Type II Diabetes Mellitus, Chronic Kidney Disease, Obesity and Non-Alcoholic Steatohepatitis

    • Hongtao Yu
    • Magnus Åstrand
    • Anis A. Khan

    Original Research Article 18 January 2024 Pages: 255 - 267